US study shows post-COVID rebound in inappropriate antibiotic prescribing
After a brief dip in March 2020, the proportion of people who received one or more inappropriate antibiotic prescriptions returned to pre-pandemic levels by the end of 2021.
After a brief dip in March 2020, the proportion of people who received one or more inappropriate antibiotic prescriptions returned to pre-pandemic levels by the end of 2021.
Objectives Little is routinely disclosed about the costs of the pivotal clinical trials that provide the key scientific evidence of the treatment benefits of new…
SCOOP: The Trump administration quietly spent $10 billion from a fund Congress created to help health care providers with Covid-19 costs, and used it on…
CTSA Program implements a large clinical trial for mild to moderate COVID-19 to test several existing drugs, including ivermectin, fluvoxamine and fluticasone.
Neuerscheinungen und Bestseller der Verlagsgruppe Droemer Knaur
Scientific American asked experts whether sleeping on a hard surface is actually beneficial for back pain
Due to length constraints on virological.org posts, we are splitting this report into two parts that should be read as a single report. This is…
A USDA analysis shows the spread in cattle started from a single spillover event from birds in the Texas panhandle that may have happened in…
The hit sci-fi show’s adviser and two other researchers discuss its portrayal of scientists and their technologies
The Defend the Flock Resource Center brings together biosecurity information and free resources from USDA and other experts.
One percent of scientific articles published in 2023 showed signs of generative AI’s potential involvement, according to a recent analysis